Medscape

Whether to Test Laboring Women for SARS-CoV-2 May Hinge on Regional Prevalence

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Labor & delivery units may need to consider regional prevalence of COVID-19 when deciding whether ...
Reuters

SARS-CoV-2 serologic testing not ready for widespread use

NEW YORK (Reuters Health) - Given what little we know about the immune response to SARS-CoV-2, it remains unclear what role serologic testing for antibodies to the virus should play, according to a ...

Javelin Sciences Becomes the First U.S. Laboratory to Offer Testing for SARS-CoV-2 Spike Protein in Serum and Exosomes

BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a pioneering certified biotechnology ...
JSTOR Daily

Clinic- and Community-Based SARS-CoV-2 Testing Among People Experiencing Homelessness in the United States, March–November 2020

Lauryn Berner, Ashley Meehan, Joseph Kenkel, Martha Montgomery, Victoria Fields, Ankita Henry, Alaina Boyer, Emily Mosites and Katherine Diaz Vickery Objective:SARS-CoV-2 testing is a critical ...

Microbix Launches First Recombinant SARS-CoV-2 Antigen for QAPs and Test Makers

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage ...